Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1994 Jun;69(6):1088–1093. doi: 10.1038/bjc.1994.213

Clinical stage 1 non-Hodgkin's lymphoma: long-term follow-up of patients treated by the British National Lymphoma Investigation with radiotherapy alone as initial therapy.

B Vaughan Hudson 1, G Vaughan Hudson 1, K A MacLennan 1, L Anderson 1, D C Linch 1
PMCID: PMC1969460  PMID: 8198975

Abstract

A retrospective analysis was performed of 451 adult patients with clinical stage 1/1E non-Hodgkin's lymphoma treated initially with radiotherapy alone. Histopathologically 208 patients had low-grade disease and 243 patients high-grade disease. The complete remission (CR) rate was higher in patients with low-grade disease (98%) than in those with high-grade disease (84%) (P < 0.0001). The relapse rate was similar in both histological categories, and relapse usually occurred within 5 years. The resulting overall actuarial percentage of patients achieving CR and remaining disease free (at 10 years) was 47% in patients with low-grade disease and 45% for those with high-grade disease. Salvage therapy was frequently successful in younger patients, and the overall cause-specific survival at 10 years was 71% for low-grade disease and 67% for high-grade disease. In those patients under 60 years of age at diagnosis, the overall cause-specific survival at 10 years was 84% and 80% for those with low-grade and high-grade disease respectively. These long-term results in young patients with clinical stage 1 disease are encouraging, and it will be difficult to demonstrate improved survival with initial chemotherapy either with or without radiotherapy, until new prognostic factors are found to identify poor-risk patients.

Full text

PDF
1092

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Crellin A. M., Hudson B. V., Bennett M. H., Harland S., Hudson G. V. Non-Hodgkin's lymphoma of the testis. Radiother Oncol. 1993 May;27(2):99–106. doi: 10.1016/0167-8140(93)90128-u. [DOI] [PubMed] [Google Scholar]
  2. Hagberg H., Pettersson U., Glimelius B., Sundström C. Prognostic factors in non-Hodgkin lymphoma stage I treated with radiotherapy. Acta Oncol. 1989;28(1):45–50. doi: 10.3109/02841868909111180. [DOI] [PubMed] [Google Scholar]
  3. Hallahan D. E., Farah R., Vokes E. E., Bitran J. D., Ultmann J. E., Golomb H. M., Weichselbaum R. R. The patterns of failure in patients with pathological stage I and II diffuse histiocytic lymphoma treated with radiation therapy alone. Int J Radiat Oncol Biol Phys. 1989 Oct;17(4):767–771. doi: 10.1016/0360-3016(89)90064-3. [DOI] [PubMed] [Google Scholar]
  4. Isaacson P., Wright D. H. Extranodal malignant lymphoma arising from mucosa-associated lymphoid tissue. Cancer. 1984 Jun 1;53(11):2515–2524. doi: 10.1002/1097-0142(19840601)53:11<2515::aid-cncr2820531125>3.0.co;2-c. [DOI] [PubMed] [Google Scholar]
  5. Jeffery G. M., Mead G. M., Whitehouse J. M., Ryall R. D. Involved field radiotherapy or chemotherapy in the management of stage I nodal intermediate grade non-Hodgkin's lymphoma. Br J Cancer. 1991 Nov;64(5):933–937. doi: 10.1038/bjc.1991.429. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Jones S. E., Miller T. P., Connors J. M. Long-term follow-up and analysis for prognostic factors for patients with limited-stage diffuse large-cell lymphoma treated with initial chemotherapy with or without adjuvant radiotherapy. J Clin Oncol. 1989 Sep;7(9):1186–1191. doi: 10.1200/JCO.1989.7.9.1186. [DOI] [PubMed] [Google Scholar]
  7. Kaminski M. S., Coleman C. N., Colby T. V., Cox R. S., Rosenberg S. A. Factors predicting survival in adults with stage I and II large-cell lymphoma treated with primary radiation therapy. Ann Intern Med. 1986 Jun;104(6):747–756. doi: 10.7326/0003-4819-104-6-747. [DOI] [PubMed] [Google Scholar]
  8. Longo D. L., Glatstein E., Duffey P. L., Ihde D. C., Hubbard S. M., Fisher R. I., Jaffe E. S., Gilliom M., Young R. C., DeVita V. T., Jr Treatment of localized aggressive lymphomas with combination chemotherapy followed by involved-field radiation therapy. J Clin Oncol. 1989 Sep;7(9):1295–1302. doi: 10.1200/JCO.1989.7.9.1295. [DOI] [PubMed] [Google Scholar]
  9. Miller T. P., Jones S. E. Is there a role for radiotherapy in localized diffuse lymphomas? Cancer Chemother Pharmacol. 1980;4(2):67–70. doi: 10.1007/BF00254024. [DOI] [PubMed] [Google Scholar]
  10. Morton J. E., Leyland M. J., Vaughan Hudson G., Vaughan Hudson B., Anderson L., Bennett M. H., MacLennan K. A. Primary gastrointestinal non-Hodgkin's lymphoma: a review of 175 British National Lymphoma Investigation cases. Br J Cancer. 1993 Apr;67(4):776–782. doi: 10.1038/bjc.1993.141. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Nissen N. I., Ersbøll J., Hansen H. S., Walbom-Jørgensen S., Pedersen-Bjergaard J., Hansen M. M., Rygård J. A randomized study of radiotherapy versus radiotherapy plus chemotherapy in stage I-II non-Hodgkin's lymphomas. Cancer. 1983 Jul 1;52(1):1–7. doi: 10.1002/1097-0142(19830701)52:1<1::aid-cncr2820520102>3.0.co;2-m. [DOI] [PubMed] [Google Scholar]
  12. O'Reilly S. E., Connors J. M. Non-Hodgkin's lymphoma. I: Characterisation and treatment. BMJ. 1992 Jun 27;304(6843):1682–1686. doi: 10.1136/bmj.304.6843.1682. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Paryani S. B., Hoppe R. T., Cox R. S., Colby T. V., Rosenberg S. A., Kaplan H. S. Analysis of non-Hodgkin's lymphomas with nodular and favorable histologies, stages I and II. Cancer. 1983 Dec 15;52(12):2300–2307. doi: 10.1002/1097-0142(19831215)52:12<2300::aid-cncr2820521224>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]
  14. Peto R., Pike M. C., Armitage P., Breslow N. E., Cox D. R., Howard S. V., Mantel N., McPherson K., Peto J., Smith P. G. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. Br J Cancer. 1977 Jan;35(1):1–39. doi: 10.1038/bjc.1977.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Richards M. A., Gregory W. M., Hall P. A., Dhaliwal H. S., Fernandez J., Stansfeld A. G., Jones A. E., Lister T. A. Management of localized non-Hodgkin's lymphoma: the experience at St. Bartholomew's Hospital 1972-1985. Hematol Oncol. 1989 Jan-Feb;7(1):1–18. doi: 10.1002/hon.2900070102. [DOI] [PubMed] [Google Scholar]
  16. Sutcliffe S. B., Gospodarowicz M. K., Bush R. S., Brown T. C., Chua T., Bean H. A., Clark R. M., Dembo A., Fitzpatrick P. J., Peters M. V. Role of radiation therapy in localized non-Hodgkin's lymphoma. Radiother Oncol. 1985 Nov;4(3):211–223. doi: 10.1016/s0167-8140(85)80086-4. [DOI] [PubMed] [Google Scholar]
  17. Timothy A. R., Lister T. A., Katz D., Jones A. E. Localized non-Hodgkin's Lymphoma. Eur J Cancer. 1980 Jun;16(6):799–807. doi: 10.1016/0014-2964(80)90133-4. [DOI] [PubMed] [Google Scholar]
  18. Vokes E. E., Ultmann J. E., Golomb H. M., Gaynor E. R., Ferguson D. J., Griem M. L., Oleske D. Long-term survival of patients with localized diffuse histiocytic lymphoma. J Clin Oncol. 1985 Oct;3(10):1309–1317. doi: 10.1200/JCO.1985.3.10.1309. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES